Annomutacin



Compound IDCDAMM02537
Common nameAnnomutacin
IUPAC name2-methyl-4-[2,8,15-trihydroxy-15-[5-(1-hydroxytridecyl)oxolan-2-yl]pentadecyl]-2H-furan-5-one
Molecular formulaC37H68O7

Experimental data

Retention time9.47
Adduct[M+H]+
Actual mz625.51
Theoretical mz625.504
Error9.31
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.9816

Identifiers and class information

Inchi keyALYPJDVVTYTPDW-UHFFFAOYNA-N
SmilesO=C1OC(C=C1CC(O)CCCCCC(O)CCCCCCC(O)C2OC(CC2)C(O)CCCCCCCCCCCC)C
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)9
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)32
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)624.94
Computed dipole moment(dipole)7.271
Total solvent accessible surface area (SASA)1304.69
Hydrophobic component of SASA (FOSA)1075.28
Hydrophilic component of SASA (FISA)197.443
Pie component of the SASA (PISA)31.963
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2356.53
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)11.5
Free energy of solvation of dipole (dip^2/V)0.0224315
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0176288
Globularity descriptor (glob)0.656408
Predicted polarizability in cubic angstroms (QPpolrz)67.912
Predicted hexadecane/gas partition coefficient (QPlogPC16)24.834
Predicted octanol/gas partition coefficient (QPlogPoct)33.665
Predicted water/gas partition coefficient (QPlogPw)14.546
Predicted octanol/water partition coefficient (QPlogPo/w)7.322
Predicted aqueous solubility (QPlogS)-9.866
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.365
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.244
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)132.906
Predicted brain/blood partition coefficient (QPlogBB)-4.42
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)55.848
Predicted skin permeability, log Kp (QPlogKp)-1.973
PM3 calculated ionization potential (IP(ev))10.38
PM3 calculated electron affinity (EA(eV))0.472
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)1.049
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)81.907
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)129.043
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43116PTGER2Prostanoid EP2 receptorT38529SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T38529DI0003Abortion[ICD-11: JA00]P43116PTGER2
T38529DI0102Coronary atherosclerosis[ICD-11: BA52]P43116PTGER2
T38529DI0121Diabetic foot ulcer[ICD-11: BD54]P43116PTGER2
T38529DI0166Glaucoma[ICD-11: 9C61]P43116PTGER2
T38529DI0356Pulmonary hypertension[ICD-11: BB01]P43116PTGER2
T38529DI0378Sexual dysfunction[ICD-11: HA00-HA01]P43116PTGER2
T38529DI0413Transplant rejection[ICD-11: NE84]P43116PTGER2

Copyright © 2025